Toxicokinetic interaction between quetiapine and antiretroviral therapy following quetiapine overdose

Drug Metabolism Letters

Volumn 4, Issue 1, 2010, Pages 7-8

  Hantson, P ^a   Fazio, V Di ^a   Wallemacq, P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Antiretroviral therapy; CYP3A4; Half life; Overdose; Quetiapine

Indexed keywords

ACTIVATED CARBON; ATAZANAVIR; LAMIVUDINE; NORADRENALIN; QUETIAPINE; RITONAVIR; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMA; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; FEMALE; FLUID THERAPY; GLASGOW COMA SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; PRIORITY JOURNAL; STOMACH LAVAGE; TOXICOKINETICS; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; HALF LIFE TIME; INTOXICATION; MIDDLE AGED;

ANTI-HIV AGENTS; ANTIPSYCHOTIC AGENTS; COMA; DIBENZOTHIAZEPINES; DRUG INTERACTIONS; FEMALE; HALF-LIFE; HIV INFECTIONS; HUMANS; HYPOTENSION; MIDDLE AGED; OVERDOSE;

EID: 77953251600     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231210790980426     Document Type: Article

References (10)

1. Hasselstrom, J.; Linnet, K. In vitro studies on quetiapine metabolism using the substrate depletion approach with focus on drug-drug interactions. Drug Metabol. Drug Interact., 2006, 21, 187-211.
2. Grimm, S.W.; Richtand, N.M.; Winter, H.R.; Stams, K.R; Reele, S.B. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br. J. Clin. Pharmacol., 2006, 61, 58-69.
3. Ngo, A.; Ciranni, M.; Olson, K.R. Acute quetiapine overdose in adults: a 5-year retrospective case series. Ann. Emerg. Med., 2008, 52, 541-547.
4. Balit, C.R.; Isbister, G.K.; Hackett, L.P.; Whyte, I.M. Quetiapine poisoning: a case series. Ann. Emerg. Med., 2003, 42, 751-758.
5. Hawkins, D.J.; Unwin, P. Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose. Crit. Care Resusc., 2008, 10, 320-322.
6. Pollak, P.T.; Zbuk, K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin. Pharmacol. Ther., 2000, 68, 92-97.
7. Bodmer, M.; Burkard, T.; Kummer, O., Beyrau, R.; Krähenbühl, S.; Haschke, M. Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose. Ther. Drug Monit., 2008, 30, 553-556.
8. Hunfeld, N.G.M.; Westerman, E.M.; Boswijk, D.J.; de Haas, J.A; van Putten, M.J.; Touw, D.J. Quetiapine overdosage. A clinical and pharmacokinetic analysis of 14 cases. Ther. Drug Monit., 2006, 28, 185-189.
9. Zhou, S.F.; Xue, C.C.; Yu X.Q.; Li, C.; Wang, G. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther. Drug Monit., 2007, 29, 687-710.
10. Pollack, T.M.; McCoy, C.; Stead, W. Clinically significant adverse events from a drug interaction between quetiapine and atazanavirritonavir in two patients. Pharmacotherapy, 2009, 29, 1386-1391.